Neopharm Labs expands into the US by acquiring Boston-based Averica Discovery

The combined expertise creates a key player in the North American analytical market 

“We are very impressed with the knowledge and scientific track record of Dr. Jeffrey Kiplinger and the entire Averica team. The combination of the companies makes us more competitive and allows us to broaden our service offerings to the life sciences industry.  Our clients will directly benefit from the merging of our companies’ skills and talents,” states Nicolas Fortin, President and General Manager of Neopharm Labs.

To view the complete press release, click on the following link :

Canadian-based Neopharm Labs Completes Acquisition of Boston-Based Averica Discovery Services